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Abstract
Introduction—Diabetes is one of the most common and fastest-growing comorbidities of 
pregnancy. Temporal trends in gestational diabetes mellitus (GDM) have not been examined at the 
state level. This study examines GDM prevalence trends overall and by age, state, and region for 
19 states, and by race/ethnicity for 12 states. Sub-analysis assesses trends among GDM deliveries 
by insurance type and comorbid hypertension in pregnancy.
Methods—Using the Agency for Healthcare Research and Quality’s National and State Inpatient 
Databases, deliveries were identified using diagnosis-related group codes for GDM and 
comorbidities using ICD-9-CM diagnosis codes among all community hospitals. General linear 
regression with a log-link and binomial distribution was used in 2014 to assess annual change in 
GDM prevalence from 2000 through 2010.
Results—The age-standardized prevalence of GDM increased from 3.71 in 2000 to 5.77 per 100 
deliveries in 2010 (relative increase, 56%). From 2000 through 2010, GDM deliveries increased 
significantly in all states (p < 0.01), with relative increases ranging from 36% to 88%. GDM 
among deliveries in 12 states reporting race and ethnicity increased among all groups (p < 0.01), 
with the highest relative increase in Hispanics (66%). Among GDM deliveries in 19 states, those 
with pre-pregnancy hypertension increased significantly from 2.5% to 4.1% (relative increase, 
64%). The burden of GDM delivery payment shifted from private insurers (absolute decrease of 
13.5 percentage points) to Medicaid/Medicare (13.2–percentage point increase).
Conclusions—Results suggest that GDM deliveries are increasing. The highest rates of increase 
are among Hispanics and among GDM deliveries complicated by pre-pregnancy hypertension.
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Diabetes is one of the most common and fastest-growing comorbidities of pregnancy.1,2 
Gestational diabetes mellitus (GDM), defined as diabetes first diagnosed during pregnancy, 
has been associated with numerous adverse perinatal outcomes such as macrosomia, or 
larger-than-normal babies,3 which leads to difficult labor and delivery4 and maternal 
morbidity.5 The risk of developing GDM is increased in women with the following risk 
factors: age >25 years, non-white race, family history of diabetes,6 GDM in a previous 
pregnancy, chronic hypertension,7 high BMI, large abdominal circumference, high fasting 
glycemia in the first trimester of pregnancy, and the presence of polycystic ovary 
syndrome.8 Further, women who suffer from GDM as well as their offspring are also at 
higher risk for developing type 2 diabetes later in life.9 Consequently, pregnancies 
complicated by GDM need to be monitored closely for obstetric complications and adverse 
mother and infant outcomes.
In a previous study, analyses found that GDM rates differ by state; the variation was 
attributable to differences in obesity at the population level, age, race/ethnicity, hospital 
status, and health insurance status.10 Information on trends at the state level is needed to 
plan and focus healthcare services as well as to develop effective healthcare practices and 
policies for diabetes prevention and control. However, data on population-based, state-
specific trends in GDM prevalence are limited. For states with available data, trends were 
assessed from 2000 through 2010 in GDM deliveries overall and by state, age, and race or 
ethnicity. Secondary analyses were conducted within the population of GDM deliveries to 
assess trends in GDM deliveries with comorbidities such as pre-eclampsia and pre-
pregnancy hypertension, and funding of GDM deliveries by type of health insurance.
Methods
Study Sample
Data were used from the 2000–2010 State Inpatient Databases (SID), sponsored by the 
Agency for Healthcare Research and Quality to identify hospital discharges involving 
diabetes diagnosed during pregnancy.11 The databases contain information on hospital 
inpatient stays from all community hospitals in states participating in the Healthcare Cost 
and Utilization Project (HCUP) and are largely a census rather than a sample of those 
hospitals; they account for approximately 86% of hospitalizations nationally. Annual data 
collection by the databases includes the 19 participating states with data from 2000 through 
2010: Arizona, California, Colorado, Florida, Hawaii, Iowa, Kentucky, Massachusetts, 
Maryland, Michigan, North Carolina, New Jersey, New York, Oregon, South Carolina, 
Utah, Washington, Wisconsin, and West Virginia.
Community hospitals are defined as short-term, nonfederal, general, and other hospitals, 
excluding hospital units of other institutions (e.g., prisons).12 Community hospitals (and 
HCUP data) include obstetrics–gynecology, ear–nose–throat, orthopedic, cancer, pediatric, 
public (e.g., county hospitals), and academic medical hospitals (e.g., university hospitals). 
Some states exclude hospitals that mainly focus on long-term care or psychiatric, 
alcoholism, or chemical-dependency treatment, although discharges from units of these 
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types that are part of community hospitals are included. Although not all states include these 
types of hospitals, the numbers of deliveries from them are few; therefore, any differences in 
the population of deliveries would be minimal.
Hospital delivery discharge codes were identified using ICD-9-CM diagnosis codes or 
diagnosis-related group (DRG) codes. DRGs comprise a patient classification system that 
categorizes hospital stays into groups that are clinically similar with respect to resource use, 
including diagnosis and type of treatment or procedure. Each hospital stay has one DRG 
assigned to it. Delivery stays were identified by discharges having a DRG code of 767–768 
and 774–775 (vaginal delivery) or 765–766 (cesarean [C]-section) during 2008–2010, or a 
DRG code 372–375 (vaginal delivery) or 370–371 (C-section) during 2000–2007.
Deliveries were identified with a GDM diagnosis by the presence of ICD-9-CM codes 
648.8x listed anywhere on the discharge record. Cases that listed both codes for GDM and 
for pre-pregnancy diabetes were excluded (n=7,725; <1%).
Measures
Examined variables included maternal age; race/ethnicity; expected primary health 
insurance; and two associated comorbidities, pre-eclampsia and pre-pregnancy hypertension. 
Race/ethnicity categories were non-Hispanic (NH) white, NH black, Hispanic, and NH 
Asian/Pacific Islander. Expected primary health insurance payer categories included private; 
Medicaid/Medicare; uninsured; or other government insurance such as Worker’s 
Compensation, Civilian Health and Medical Program of the Uniformed Services, Civilian 
Health and Medical Program of the Department of Veterans Affairs, Title V, or other 
government program. Pre-eclampsia was defined by the presence of ICD-9-CM codes 
642.3x–642.6x listed anywhere on the discharge record, and pre-pregnancy hypertension by 
ICD-9-CM codes 642.0x, 642.2x, 642.7x, 401.0x, 401.1x, 401.9x, 437.2x, or 402.xx–
405.xx13 listed anywhere on the discharge record. Medicaid and Medicare were combined, 
though deliveries expected to be funded by Medicare comprised only about 1% of the total. 
Pre-pregnancy BMI was not available on maternal hospital discharges and therefore was not 
included. Data were not reported for California in 2002 or for Hawaii in 2005, and seven 
states did not report race or ethnicity during the entire study period (Iowa, Kentucky, North 
Carolina, Oregon, Utah, Washington, and West Virginia).
Statistical Analysis
Age-standardized rates of GDM were estimated for each state, region, and the selected 
subgroups, using the national number of deliveries from 2000 (i.e., the Nationwide Inpatient 
Sample [NIS] from HCUP) for age standardization. For the 12 states with race/ethnicity, 
age- and race- standardized rates were computed using data from the 2000 NIS. A 
subanalysis was also conducted to assess trends within the population of GDM deliveries. 
Those analyses included assessing trends among women with GDM in comorbidities such as 
pre-eclampsia and pre-pregnancy hypertension as well as changes in funding of GDM 
deliveries by insurance type. SAS, version 9.3, and SUDAAN, version 11.0.0, were used for 
data management and analyses to produce estimates. The number of deliveries was obtained 
by DRG codes from the HCUPnet online query system11 for California in 2002 and Hawaii 
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in 2005, and, using PROC MI in SAS, all variables were imputed for those years based on 
data (e.g., race/ethnicity, age, GDM, pre-pregnancy diabetes status, insurance type, pre-
eclampsia, pre-pregnancy hypertension) from other years within the same state. Less than 
1% of data were missing for variables other than race/ethnicity for the rest of the states and 
years but, for consistency, those were also imputed. The one exception was among the 12 
states reporting race and ethnicity: race and ethnicity were missing on average 26.2% per 
year and were imputed from available data in the same state. Potential bias due to the large 
proportion with missing race was assessed with a sensitivity analysis comparing complete 
case rates of GDM deliveries with imputed rates. General linear regression with a log-link 
and binomial distribution was used in 2014 to assess the annual change over 11 years from 
2000 through 2010 and to test for a statistically significant change in prevalence over time. 
Because the change in total number of deliveries is informative about the change in GDM 
prevalence over time, statistically significant annual changes in total number of deliveries by 
characteristics assessed are presented. For example, if GDM prevalence is increasing 
significantly, knowing whether the total number of deliveries dropped, remained constant, or 
increased in relation to increase in GDM deliveries is more informative than only reporting 
change in GDM prevalence. This study was reviewed by the Human Subjects Coordinator at 
CDC and, as an analysis of secondary data without identifiers, was determined to be exempt 
from IRB review.
Results
Overall, the age-standardized prevalence of GDM deliveries in the 19 states increased 
significantly from 3.71 in 2000 to 5.77 per 100 deliveries in 2010 (relative change, 56%; 
annual change, p < 0.01) (Table 1). The greatest relative increase was seen in Utah (1.95 to 
3.66 per 100 deliveries; relative increase, 88%); the smallest increase was seen in Maryland 
(4.26 to 5.80 per 100 deliveries; relative increase, 36%). In the last 2 years, four of the five 
states with the highest prevalence of GDM (≥6.00 per 100 births) were in the Western 
region, including California, Oregon, Washington, and Hawaii. The four regional trends of 
GDM prevalence increased significantly as well (p < 0.001). The Midwestern and Western 
regions increased more (relative increases of 69% and 64%, respectively) than the Northern 
and Southern regions (relative increases of 44% and 47%, respectively).
GDM rates for all age groups in all 19 states increased significantly (p < 0.01) (Table 2). 
The greatest relative increase in GDM deliveries occurred among those aged 15–24 years 
(range, 59%–66%). Among age groups, the absolute increase in GDM deliveries followed a 
dose response, increasing with older age.
GDM among deliveries increased significantly (p < 0.01) among all race/ethnicity groups in 
the 12 states reporting race and ethnicity, with the highest relative increase in Hispanics 
(66%). Yet, throughout the study time period, NH Asians had the highest prevalence of 
GDM (range, 6.48%–10.27%). Age- and race-standardized GDM rates were consistently 
higher than crude GDM rates in these 12 states (Figure 1). Complete case rates of GDM 
deliveries were consistently lower than imputed rates for all race/ethnicity groups. This 
difference was nearly identical for NH whites, Hispanics, and NH Asians (within 9% on 
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average). For NH blacks, the complete case rates were much closer to the imputed rates 
(within <1% on average).
From 2000 through 2010, among GDM deliveries, the proportion with comorbidities 
increased significantly: pre-pregnancy hypertension from 2.5% to 4.1% (relative increase, 
64%) and pre-eclampsia from 9.8% to 11.0% (relative increase, 12%) (Figure 2). The 
prevalence of Medicaid/Medicare funding of GDM deliveries increased from 37.6% to 
50.8% (absolute increase, 13.2 percentage points) (p < 0.01), and the prevalence of private 
insurers funding GDM deliveries decreased from 57.5% to 44.0% (absolute decrease, 13.5 
percentage points) (p < 0.01) (Figure 3).
The number of GDM deliveries increased significantly (p < 0.001) from 75,212 in 2000 to 
119,229 in 2010 in the 19 states (relative increase, 59%). Over the 11-year period, 
significant increases (p < 0.05) in the total number of deliveries occurred among women 
aged 25–29 years (relative increase, 3%) and 40–44 years (relative increase, 19%); Hispanic 
(relative increase, 18%) and NH Asian/Pacific Islander women (relative increase, 32%); and 
deliveries with Medicare/Medicaid (relative increase, 31%). Conversely, statistically 
significant decreases occurred in the total number of deliveries among NH whites (relative 
decrease, 11%) and women with private insurance (relative decrease, 24%).
Discussion
The results of this study suggest that GDM delivery rates increased across all demographic 
groups (e.g., age, race/ethnicity). State and regional differences in GDM prevalence may 
reflect race and ethnicity differences in deliveries overall. Western states had the highest 
prevalence of GDM deliveries and also had the highest proportion of Asians.14 Throughout 
the study period, the highest rates of GDM were found among NH Asian and Pacific 
Islander women. Studies have shown that even at normal or low BMI, Asians have much 
higher risk of GDM compared with their NH white counterparts.15 Notably, the rate of 
GDM in NH Asian women is increasing more because of the much faster pace of increase in 
GDM deliveries (numerator) compared with that of the total deliveries (denominator), as the 
latter has also increased significantly.
Among the 12 states, with race/ethnicity, the age- and race-standardized rates were 
consistently higher than the crude rates, probably because of higher prevalence among older 
and non-white women. The highest relative increase in GDM by race/ethnicity was among 
Hispanics and may be related to increases in obesity prevalence during 1999–2008, which 
were greater among Mexican American women aged 20–39 years (from 30.6% to 39.6%) 
compared to black women (from 46.2% to 47.2%) and white women (from 28.4% to 
34.0%).16 Also, the greatest absolute increase in GDM was in the West, the region with the 
highest proportion of Hispanics in 2010 (28.6%).17 The annual increase in number of 
deliveries (denominator) was statistically significant among Hispanic women, meaning that 
the increase in GDM among Hispanic women (numerator) was even greater than the 
increase in deliveries.
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GDM deliveries have become more complicated as those with comorbidities such as pre-
pregnancy hypertension and pre-eclampsia have increased. Pre-eclampsia is a leading cause 
of maternal and perinatal mortality and morbidity,18 and hypertensive disorders during 
pregnancy are major contributors to prematurity, small-for-gestational-age status, poor 
Apgar scores, C-sections, stillbirths, and early neonatal deaths.19 In addition, both the 
mother and infant are at increased risk for future cardiovascular disease and type 2 
diabetes.20
GDM disproportionately burdens those with lower SES,21 and this may add to demands on 
publicly funded healthcare programs. Throughout the study period, the proportion of GDM 
deliveries funded by Medicaid/Medicare increased significantly. In addition, the annual 
increase in the number of deliveries funded by Medicaid/Medicare (denominator) was 
statistically significant; this means that the increase in GDM publicly funded deliveries 
(numerator) was even greater than the increase in the number of deliveries among women on 
Medicaid/Medicare. Starting in 1991, all state Medicaid programs were required to cover 
pregnant women with incomes <133% of the federal poverty level.22 Since 2000, there was 
a shift in GDM deliveries from being funded by private insurance to being funded by 
Medicaid/Medicare. The increase in GDM deliveries with comorbid conditions will likely 
impact the cost to insurers, and this may be an important area for further research.
This study’s strengths include data that were population-based, available at a state level, and 
reflected trends over an 11-year period. Although all states were not represented and, 
therefore, results could not be generalized to the U.S., each region of the country was 
represented by at least three states. We are aware of no data source that covers all states for 
state-specific estimates.
Limitations
This study was subject to several limitations. One limitation was inconsistent availability of 
race/ethnicity data both across and within states, meaning that GDM rates for race and 
ethnicity do not represent the 19 states in the entire study population. However, sensitivity 
analyses suggest conclusions would not have changed. Also, Indian Health Services 
hospitals are not included in the SID; thus, the sample of Native Americans’ deliveries in 
community hospitals was too small to report.
Variability in GDM rates may reflect reporting artifacts and the extent to which screening 
for GDM occurs, as rates of screening and reporting likely vary by type of health insurance 
and hospital characteristics. Further, screening recommendations for GDM changed during 
the study, and no data regarding screening practices were available.
No data on pre-pregnancy weight or BMI were available. One study found that for certain 
race/ethnicity groups, as many as 60% of GDM cases could be prevented if women entered 
pregnancy at a normal, healthy weight.23 In addition, women who are obese are four to eight 
times more likely to develop GDM.24 Therefore, the increasing prevalence of GDM in this 
study was likely strongly associated with rising levels of obesity during this period. Further, 
because ICD diagnosis codes were used, it was unclear whether increases could have been 
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attributable in part to improved assessment or been driven by greater prevalence of 
underlying risk factors for GDM.
Finally, using ICD codes may have resulted in underestimation of GDM prevalence and 
complications such as hypertension in deliveries. One study found that using ICD codes for 
hypertension in deliveries had sensitivity as low as 58%.25 This study found that fewer than 
2% of all deliveries were reported to be affected by hypertension, though one study reported 
that hypertension occurs in 5%–10% of pregnancies.26
Conclusions
Contributions of this study include the findings that GDM prevalence increased across 
demographic groups, and the proportion of GDM deliveries complicated by pre-pregnancy 
hypertension also increased. This clinical combination places children of mothers with 
GDM at risk for serious adverse outcomes. This study also found that the burden of funding 
GDM deliveries shifted from private insurance to public payers during the examined time 
period.
Effective diabetes prevention and control strategies for women of childbearing age can help 
to protect the health of women and their newborns. Structured lifestyle changes or 
pharmaceutical interventions can prevent or delay type 2 diabetes among women with a 
history of GDM,27 and these interventions can start before and during pregnancy.28 
Breastfeeding also may mitigate the risk of developing type 2 diabetes for mothers, 
particularly those who are obese or who have GDM, and for their offspring as they grow 
into adulthood.29,30
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Crude and age- and race-standardized rates of gestational diabetes mellitus (GDM), 12 
states: 2000–2010.
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Proportion of gestational diabetes mellitus deliveries with hypertension, 19 states: 2000–
2010.
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Proportion of gestational diabetes mellitus deliveries by expected primary payer, 19 states: 
2000–2010.
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